Can You Trust This Cardiac Company's Big Gains?

Before you go, we thought you'd like these...
Before you go close icon

It's safe to say medical-device maker St. Jude Medical has had a big year. This stock's jumped more than 50% year to date as part of health care's rise in 2013. However, as shares have risen, St. Jude's sales and earnings haven't taken the same path higher.

How dicey is this company's financial situation? St. Jude's pacemaker and implantable cardioverter defibrillator sales, which make up a majority of the firm's revenue, have sunk over the first six months of the year. Meanwhile, the company's closest competitors are showing signs of a comeback while St. Jude's biggest growth segment lags behind these rivals.

Can St. Jude keep up its run, or is this stock bound to fall back to Earth? In the following video, Motley Fool contributor Dan Carroll tells you what's ahead for St. Jude -- and what investors need to watch if this company's going to turn around its struggling businesses.

How you can jump-start your financial success
Even though St. Jude's struggling, its stock has soared in 2013. Yet much of the stock market's big gains since the recession have come as millions of Americans have waited on the sidelines since the market meltdown in 2008 and 2009, too scared to invest and put their money at further risk. Yet those who've stayed out of the market have missed out on huge gains and put their financial futures in jeopardy. In our brand-new special report, "Your Essential Guide to Start Investing Today," The Motley Fool's personal-finance experts show you why investing is so important and what you need to do to get started. Click here to get your copy today -- it's absolutely free.

The article Can You Trust This Cardiac Company's Big Gains? originally appeared on

Fool contributor Dan Carroll has no position in any stocks mentioned. The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

People are Reading